These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 3203995)
21. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. Ogan MD; Schmiedl U; Moseley ME; Grodd W; Paajanen H; Brasch RC Invest Radiol; 1987 Aug; 22(8):665-71. PubMed ID: 3667174 [TBL] [Abstract][Full Text] [Related]
22. MR imaging of pulmonary parenchyma and emboli by paramagnetic and superparamagnetic contrast agents. Thakur ML; Vinitski S; Mitchell DG; Consigny PM; Lin S; DeFulvio J; Rifkin M Magn Reson Imaging; 1990; 8(5):625-30. PubMed ID: 2082134 [TBL] [Abstract][Full Text] [Related]
23. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Hamm B; Staks T; Mühler A; Bollow M; Taupitz M; Frenzel T; Wolf KJ; Weinmann HJ; Lange L Radiology; 1995 Jun; 195(3):785-92. PubMed ID: 7754011 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues. Wang SC; Wikström MG; White DL; Klaveness J; Holtz E; Rongved P; Moseley ME; Brasch RC Radiology; 1990 May; 175(2):483-8. PubMed ID: 1691513 [TBL] [Abstract][Full Text] [Related]
25. From the relaxivity of Gd(DTPA)2- to everything else. Koenig SH Magn Reson Med; 1991 Dec; 22(2):183-90. PubMed ID: 1812344 [TBL] [Abstract][Full Text] [Related]
26. Delayed magnetic resonance hepatic imaging with gadolinium-DTPA. Nelson RC; Umpierrez ME; Chezmar JL; Bernardino ME Invest Radiol; 1988 Jul; 23(7):509-11. PubMed ID: 3170138 [TBL] [Abstract][Full Text] [Related]
27. A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI. Weinmann HJ; Schuhmann-Giampieri G; Schmitt-Willich H; Vogler H; Frenzel T; Gries H Magn Reson Med; 1991 Dec; 22(2):233-7; discussion 242. PubMed ID: 1812351 [TBL] [Abstract][Full Text] [Related]
28. Capillary leakage of a macromolecular MRI agent, carboxymethyldextran-Gd-DTPA, in the liver: pharmacokinetics and imaging implications. Siauve N; Clément O; Cuénod CA; Benderbous S; Frija G Magn Reson Imaging; 1996; 14(4):381-90. PubMed ID: 8782176 [TBL] [Abstract][Full Text] [Related]
29. Does gadolinium-diethylene triamine pentaacetic acid enhanced MRI of kidney represent tissue concentration of contrast media in the kidney? In vivo and in vitro study. Takeda M; Katayama Y; Tsutsui T; Komeyama T; Mizusawa T Magn Reson Imaging; 1994; 12(3):421-7. PubMed ID: 8007771 [TBL] [Abstract][Full Text] [Related]
30. The value of paramagnetic contrast agent gadolinium-DTPA in the diagnosis of pituitary adenomas. Nakamura T; Schörner W; Bittner RC; Felix R Neuroradiology; 1988; 30(6):481-6. PubMed ID: 3226534 [TBL] [Abstract][Full Text] [Related]
31. Gadolinium-labeled liposomes: targeted MR contrast agents for the liver and spleen. Kabalka G; Buonocore E; Hubner K; Moss T; Norley N; Huang L Radiology; 1987 Apr; 163(1):255-8. PubMed ID: 3454163 [TBL] [Abstract][Full Text] [Related]
32. Concentration of gadolinium-diethylene triamine pentaacetic acid in human kidney--study on proper time for dynamic magnetic resonance imaging of the human kidney on low and high magnetic fields. Takeda M; Katayama Y; Tsutsui T; Komeyama T; Mizusawa T; Tanikawa T; Sato S Tohoku J Exp Med; 1993 Oct; 171(2):119-28. PubMed ID: 8128480 [TBL] [Abstract][Full Text] [Related]
33. Paramagnetic liposomes containing amphiphilic bisamide derivatives of Gd-DTPA with aromatic side chain groups as possible contrast agents for magnetic resonance imaging. Parac-Vogt TN; Kimpe K; Laurent S; Piérart C; Elst LV; Muller RN; Binnemans K Eur Biophys J; 2006 Jan; 35(2):136-44. PubMed ID: 16217648 [TBL] [Abstract][Full Text] [Related]
34. Biodistribution of GdCl3 and Gd-DTPA and their influence on proton magnetic relaxation in rat tissues. Barnhart JL; Kuhnert N; Bakan DA; Berk RN Magn Reson Imaging; 1987; 5(3):221-31. PubMed ID: 3626790 [TBL] [Abstract][Full Text] [Related]
35. Gd-labeled liposomes containing amphipathic agents for magnetic resonance imaging. Kabalka GW; Davis MA; Buonocore E; Hubner K; Holmberg E; Huang L Invest Radiol; 1990 Sep; 25 Suppl 1():S63-4. PubMed ID: 2283259 [No Abstract] [Full Text] [Related]
36. Detailed toxicity studies of liposomal gadolinium-DTPA. Fritz T; Unger E; Wilson-Sanders S; Ahkong QF; Tilcock C Invest Radiol; 1991 Nov; 26(11):960-8. PubMed ID: 1835967 [TBL] [Abstract][Full Text] [Related]
37. The use of a binary chelate formulation: Could gadolinium based linear contrast agents be rescued by the addition of zinc selective chelates? Gibby W; Parish W; Merrill RM; Fernandez D; Anderson CR; Merchel E; Parr R Magn Reson Imaging; 2019 May; 58():76-81. PubMed ID: 30639754 [TBL] [Abstract][Full Text] [Related]
38. In vivo MR evaluation of Gd-DTPA conjugated to dextran in normal rabbits. Li KC; Quisling RG; Armitage FE; Richardson D; Mladinich C Magn Reson Imaging; 1992; 10(3):439-44. PubMed ID: 1383670 [TBL] [Abstract][Full Text] [Related]
39. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946 [TBL] [Abstract][Full Text] [Related]